Market Overview
The US market for drug delivery devices andtechnology was one of the most profi table andquickly growing markets in the US medical devicesand healthcare fi elds. In 2004, it was valuedaproximaly $65 million and has shown enormousgrowth over the past decade. This growth willcontinue over the forecast period of the next fi veyears and into the future as new technologies arecontinually introduced. By 2009, the US drug deliverymarket will be valued at almost $140 million.
Competitors Coverage
- BD
- Ypsomed
- DEY
- AstraZeneca
- Boston Scientifi c
- 3M
- Cordis
Report Benefi ts
- Find out how new developments ininfusion affect the Drug Delivery market
- Plan effective strategies with in-depthinsights into:
- unit volumes
- average sales price
- competitor market shares
- Profi t from new opportunities and give yourcompany the competitive advantage
- AlZA
- Noven
- Pfeiffer
- Valois
- Saint-Gobain Calmar
View Cart
